Search results for "TOLERANCE TEST"

showing 8 items of 78 documents

Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial low-density lipoprotein size and subclasses in patients with Type 2…

2008

To assess the effects of pioglitazone and rosiglitazone on fasting and postprandial low-density lipoprotein (LDL) size and subclasses in patients with Type 2 diabetes.Nine Type 2 diabetic patients (age 61 +/- 10 years, body mass index 30 +/- 5 kg/m(2), glycosylated hemoglobin [HbA1c] 7.5 +/- 0.5%) were randomized in a crossover trial to rosiglitazone 4 mg b.i.d. or pioglitazone 45 mg/day for 12 weeks with an 8-week wash-out period. LDL size and subclasses were determined by non-denaturing polyacrylamide gradient gel electrophoresis. A standardized breakfast was served and variables were assessed after 3 and 6 h.HbA1c, insulin sensitivity (as assessed by the homeostasis model assessment) and…

Malemedicine.medical_specialtyType 2 diabetesRosiglitazonechemistry.chemical_compoundDiabetes mellitusInternal medicinemedicineHumansHypoglycemic AgentsPharmacology (medical)Prospective StudiesTriglyceridesPharmacologyGlycated HemoglobinCross-Over StudiesTriglyceridePioglitazoneCholesterolbusiness.industryGeneral MedicineCholesterol LDLFastingGlucose Tolerance TestMiddle Agedmedicine.diseasePostprandial PeriodLipoproteins LDLPostprandialEndocrinologychemistryDiabetes Mellitus Type 2Low-density lipoproteindense LDL diabetes LDL size pioglitazone postprandial rosiglitazoneElectrophoresis Polyacrylamide GelFemaleThiazolidinedionesbusinessRosiglitazonePioglitazonemedicine.drug
researchProduct

Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at car…

2007

We investigated the effect of pioglitazone in comparison with and in combination with simvastatin on insulin resistance, plasma adiponectin, postprandial plasma glucose, insulin, and intact proinsulin levels in a nondiabetic population at cardiovascular risk. One hundred twenty-five nondiabetic patients at cardiovascular risk were randomized to pioglitazone (PIO), pioglitazone and simvastatin (PIO/SIM), or simvastatin (SIM) treatments. Blood samples were taken for the measurement of adiponectin and lipid levels. In addition, an oral glucose load with the measurements of glucose, insulin, and intact proinsulin levels was performed. Adiponectin levels increased from 14.0 ± 8.2 to 27.6 ± 14.5 …

Simvastatinmedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentPopulationEndocrinologyInsulin resistanceDouble-Blind MethodRisk FactorsInternal medicineInsulin SecretionHumansHypoglycemic AgentsInsulinMedicineProspective StudieseducationProinsulineducation.field_of_studyPioglitazoneAdiponectinbusiness.industryInsulinnutritional and metabolic diseasesGlucose Tolerance Testmedicine.diseasePostprandialEndocrinologyCardiovascular DiseasesSimvastatinThiazolidinedionesAdiponectinInsulin ResistancebusinessPioglitazoneProinsulinmedicine.drugMetabolism
researchProduct

Acute selective ablation of rat insulin promoter-expressing (RIP HER ) neurons defines their orexigenic nature

2012

Rat insulin promoter (RIP)-expressing neurons in the hypothalamus control body weight and energy homeostasis. However, genetic approaches to study the role of these neurons have been limited by the fact that RIP expression is predominantly found in pancreatic β-cells, which impedes selective targeting of neurons. To define the function of hypothalamic RIP-expressing neurons, we set out to acutely and selectively eliminate them via diphtheria toxin-mediated ablation. Therefore, the diphtheria toxin receptor transgene was specifically expressed upon RIP-specific Cre recombination using a RIP-Cre line first described by Herrera (RIP HER -Cre) [Herrera PL (2000) Development 127:2317–2322]. Usi…

endocrine systemmedicine.medical_specialtyPituitary glandBiologyReal-Time Polymerase Chain ReactionEnergy homeostasisMiceArcuate nucleusOrexigenicInternal medicineWeight LossmedicineAnimalsInsulinPromoter Regions GeneticDorsomedial hypothalamic nucleusNeuronsDiphtheria toxinMultidisciplinarydigestive oral and skin physiologyArcuate Nucleus of HypothalamusFeeding BehaviorBiological SciencesGlucose Tolerance TestRatsEndocrinologymedicine.anatomical_structurenervous systemHypothalamusNucleushormones hormone substitutes and hormone antagonistsParaventricular Hypothalamic Nucleusmedicine.drugProceedings of the National Academy of Sciences
researchProduct

Use of the Diabetes Risk Score for Opportunistic Screening of Undiagnosed Diabetes and Impaired Glucose Tolerance

2005

OBJECTIVE—To evaluate an opportunistic screening strategy addressed to individuals with one or more cardiovascular risk factor, based on the Diabetes Risk Score (DRS) as the initial instrument, for the identification of individuals with type 2 diabetes or impaired glucose tolerance (IGT). RESEARCH DESIGN AND METHODS—The DRS, a simple self-administered questionnaire, was completed by individuals identified by general practitioners and presenting with one or more cardiovascular risk factor. All patients underwent a 2-h oral glucose tolerance test (OGTT). The optimal DRS cutoff was calculated by applying the receiver-operating characteristic curve. RESULTS—Overall, 1,377 individuals aged betwe…

medicine.medical_specialtyDiabetes riskEndocrinology Diabetes and MetabolismType 2 diabetesImpaired glucose toleranceMELLITUSNIDDMPEOPLEInternal medicineDiabetes mellitusInternal MedicinemedicineRisk factorProspective cohort studyAdvanced and Specialized NursingGlucose tolerance testmedicine.diagnostic_testbusiness.industryPERFORMANCEmedicine.diseaseImpaired fasting glucosePREVENTIONPREVALENCEEndocrinologyLIFE-STYLEHEALTHbusinessDiabetes Care
researchProduct

NEW INTERPRETATION OF ORAL GLUCOSE TOLERANCE

1964

medicine.medical_specialtyGlucose tolerance testmedicine.diagnostic_testDuodenumbusiness.industryResearchGeneral MedicineGlucose Tolerance TestGastroenterologyIntestinal absorptionInjectionsJejunumDogsGlucoseJejunummedicine.anatomical_structureIntestinal AbsorptionInternal medicineInjections IntravenousmedicineDuodenumAnimalsOral glucose tolerancebusinessThe Lancet
researchProduct

Effects of Fasting and Glucose Load on Free Cortisol Responses to Stress and Nicotine1

1997

The availability of energy appears to exert important regulatory functions in pituitary-adrenal stress responses. In two studies, the effects of short-term fasting and subsequent glucose administration on the free cortisol response to psychological stress and nicotine consumption were investigated. Study 1: After fasting for 8-11 h, healthy young men ingested either 100 g glucose (n = 13) or water (n = 12). One hour later they were exposed to a psychosocial stress task (Trier Social Stress Test). A third group also ingested 100 g glucose, but they were not exposed to any additional treatment (n = 10). Capillary blood glucose levels were in the lower euglycemic range before and significantly…

medicine.medical_specialtyGlucose tolerance testmedicine.diagnostic_testbusiness.industryEndocrinology Diabetes and Metabolismmedicine.medical_treatmentBiochemistry (medical)Clinical BiochemistryStimulationBiochemistryNicotineSteroid hormoneEndocrinologyEndocrinologyInternal medicinemedicineTrier social stress testAnimal studiesbusinessGlucocorticoidmedicine.drugHydrocortisoneThe Journal of Clinical Endocrinology & Metabolism
researchProduct

High-Fat Diet Induces Pre-Diabetes and Distinct Sex-Specific Metabolic Alterations in Negr1-Deficient Mice

2021

In the large GWAS studies, NEGR1 gene has been one of the most significant gene loci for body mass phenotype. The purpose of the current study was to clarify the role of NEGR1 in the maintenance of systemic metabolism, including glucose homeostasis, by using both male and female Negr1−/− mice receiving a standard or high fat diet (HFD). We found that 6 weeks of HFD leads to higher levels of blood glucose in Negr1−/− mice. In the glucose tolerance test, HFD induced phenotype difference only in male mice

obesitymedicine.medical_specialtyQH301-705.5Medicine (miscellaneous)BiologyArticleGeneral Biochemistry Genetics and Molecular Biologychemistry.chemical_compoundDownregulation and upregulationgenetic modelsInternal medicineGenetic modelmedicineGlucose homeostasisBiology (General)Fatty acid synthesisGlucose tolerance testmedicine.diagnostic_testnutritional and metabolic diseasesMetabolismmetabolic diseasemetabolomicsNegr1Protein catabolismEndocrinologyglucose intoleranceGluconeogenesischemistry<i>Negr1</i>Biomedicines
researchProduct

Kuormituskoe modernin kuvantamisen aikakaudella

2019

Kuormituskoetta käytetään sepelvaltimotaudin ja muidenkin sydänsairauksien diagnosoinnissa, ennusteen arvioinnissa, hoidon suunnittelussa ja seurannassa. Kuormituskokeen keskeisin etu on sen helppo saatavuus sekä avoterveydenhuollossa että erikoissairaanhoidossa. Rasitukseen liittyvien oireiden tai suorituskyvyn heikkenemisen yhteydessä kuormituskoe on edelleen arvokas perustutkimus. Sen käytön keskeisin rajoite liittyy sen diagnostiseen osuvuuteen, ja sepelvaltimotaudin ali- ja ylidiagnostiikan välttämiseksi kuormituskokeen käyttö tulisikin rajata liikuntakykyisiin potilaisiin, joilla taudin todennäköisyys ennen testiä on keskisuuri tai suuri. Kuormituskoe sopii potilaille, joiden lepo-EKG…

rasituskokeetheart diseaseskuvantaminencoronary artery disease (CAD)sepelvaltimotautidiagnosticstolerance testssydäntauditdiagnostiikka
researchProduct